CN104353108A - 一种应用于血管吻合术及血管内闭塞术的注射剂 - Google Patents
一种应用于血管吻合术及血管内闭塞术的注射剂 Download PDFInfo
- Publication number
- CN104353108A CN104353108A CN201410513127.3A CN201410513127A CN104353108A CN 104353108 A CN104353108 A CN 104353108A CN 201410513127 A CN201410513127 A CN 201410513127A CN 104353108 A CN104353108 A CN 104353108A
- Authority
- CN
- China
- Prior art keywords
- injection
- endovascular occlusion
- angiostomy
- poloxamer
- blood vessel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002347 injection Methods 0.000 title claims abstract description 59
- 239000007924 injection Substances 0.000 title claims abstract description 59
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 18
- 230000003872 anastomosis Effects 0.000 title abstract description 12
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229920001983 poloxamer Polymers 0.000 claims abstract description 18
- 229960000502 poloxamer Drugs 0.000 claims abstract description 18
- 230000002792 vascular Effects 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims description 16
- 230000008859 change Effects 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 239000008215 water for injection Substances 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 230000004087 circulation Effects 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000006870 function Effects 0.000 abstract description 4
- 230000000903 blocking effect Effects 0.000 abstract description 3
- 239000002184 metal Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- 230000023597 hemostasis Effects 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 22
- 229920001993 poloxamer 188 Polymers 0.000 description 11
- 229940044519 poloxamer 188 Drugs 0.000 description 11
- 210000000709 aorta Anatomy 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229940027278 hetastarch Drugs 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 241000255925 Diptera Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410513127.3A CN104353108B (zh) | 2014-09-29 | 2014-09-29 | 一种应用于血管吻合术或血管内闭塞术的注射剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410513127.3A CN104353108B (zh) | 2014-09-29 | 2014-09-29 | 一种应用于血管吻合术或血管内闭塞术的注射剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104353108A true CN104353108A (zh) | 2015-02-18 |
CN104353108B CN104353108B (zh) | 2018-08-07 |
Family
ID=52520479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410513127.3A Active CN104353108B (zh) | 2014-09-29 | 2014-09-29 | 一种应用于血管吻合术或血管内闭塞术的注射剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104353108B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273860A (zh) * | 2000-05-12 | 2000-11-22 | 苏州医学院附属第一医院 | 一种血管栓塞剂及其制备工艺 |
WO2004084703A2 (en) * | 2003-03-24 | 2004-10-07 | Biosphere Medical, Inc. | Temporary embolization using inverse thermosensitive polymers |
US20080031847A1 (en) * | 2005-12-22 | 2008-02-07 | Pluromed, Inc. | Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
CN103432632A (zh) * | 2013-09-16 | 2013-12-11 | 姚静 | 一种温度敏感凝胶组合物及制备方法 |
-
2014
- 2014-09-29 CN CN201410513127.3A patent/CN104353108B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273860A (zh) * | 2000-05-12 | 2000-11-22 | 苏州医学院附属第一医院 | 一种血管栓塞剂及其制备工艺 |
WO2004084703A2 (en) * | 2003-03-24 | 2004-10-07 | Biosphere Medical, Inc. | Temporary embolization using inverse thermosensitive polymers |
CN1794980A (zh) * | 2003-03-24 | 2006-06-28 | 生物领域医疗公司 | 利用逆向热敏聚合物的暂时栓塞 |
US20080031847A1 (en) * | 2005-12-22 | 2008-02-07 | Pluromed, Inc. | Methods and kits for treating lacerations and puncture wounds using inverse thermosensitive polymers |
CN103432632A (zh) * | 2013-09-16 | 2013-12-11 | 姚静 | 一种温度敏感凝胶组合物及制备方法 |
Non-Patent Citations (2)
Title |
---|
ARIF GUCU等: ""Effects of temporary vascular occluder poloxamer 407 Gel on the endothelium"", 《JOURNAL OF CARDIOTHORACIC SURGERY》, vol. 16, no. 8, 31 August 2013 (2013-08-31), pages 1 - 7 * |
郑俊民等: "《药用高分子材料学》", 31 August 2000, article ""药用合成高分子材料"", pages: 166-167 * |
Also Published As
Publication number | Publication date |
---|---|
CN104353108B (zh) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7333425B2 (ja) | 精製された両親媒性ペプチド組成物を用いた、外科的方法 | |
JP4979150B2 (ja) | 血管塞栓形成法 | |
JP5148030B2 (ja) | 新規の高粘度塞栓形成組成物 | |
Kanehira et al. | How secure are the arteries occluded by a newly developed ultrasonically activated device? | |
US9844597B2 (en) | Biocompatible in situ hydrogel | |
CN103432632B (zh) | 一种温度敏感凝胶组合物及制备方法 | |
US7374568B2 (en) | Methods for embolizing aneurysmal sites with a high viscosity embolizing composition | |
Bouchot et al. | Clinical experience with a novel thermosensitive temporary coronary artery occluder (LeGoo) | |
CN102989036A (zh) | 应用于血管吻合术的含有肝素-泊洛沙姆复合物的水凝胶及其制备方法 | |
JP2010083788A (ja) | 架橋ゼラチン、塞栓剤および架橋ゼラチンの製造方法 | |
EP1601392B1 (en) | Compositions for use in embolizing blood vessels comprising high levels of contrast agent | |
JP2002114687A (ja) | 塞栓材料 | |
Barker et al. | Experimental study of the relationship between alterations in tissue perfusion and anastomotic patency | |
CN104353108A (zh) | 一种应用于血管吻合术及血管内闭塞术的注射剂 | |
US11559602B2 (en) | Sol for tissue perforation closure, ulcer protection, and vascular embolization | |
CN102989035B (zh) | 一种应用于血管吻合术的水凝胶及其制备方法 | |
Kanehira et al. | Development of a 23.5 kHz ultrasonically activated device for laparoscopic surgery | |
Genest | Experimental use of intraluminal plastics in the treatment of carotid aneurysms: preliminary report | |
CN103126973B (zh) | 用于血管瘤治疗的多糖水凝胶液体栓塞剂及其制备方法 | |
JPH0517369A (ja) | 血管塞栓剤 | |
JP2010162063A (ja) | 塞栓材 | |
AU2021100578A4 (en) | Use of thermosensitive material in preparation of injection for protecting perihepatic structure during thermal ablation | |
RU2669801C1 (ru) | Полимерный материал медицинского назначения для эмболизации | |
WO2023177392A1 (en) | Tissue displacement foam | |
RU2810584C1 (ru) | Термоуправляемая композиция для временной остановки кровотечений |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160224 Address after: 264000 No. 32, No. 2, Zhujianglu Road, Yantai economic and Technological Development Zone, Shandong, China Applicant after: YANTAI YENE BIOMEDICAL TECHNOLOGY Co.,Ltd. Applicant after: NANJING KANGBOSI PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: First Institute of 669-18, Xuanwu Avenue Xuanwu District of Nanjing province Jiangsu 210000 building 18 Applicant before: NANJING KANGBOSI PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240315 Address after: Room 415, 4th Floor, No. 371 Taiping South Road, Qinhuai District, Nanjing City, Jiangsu Province, 210000 Patentee after: NANJING BAIXINYU MEDICINE Co.,Ltd. Country or region after: China Address before: 264000 No. 2, No. 32 Zhujianglu Road, Yantai economic and Technological Development Zone, Shandong Patentee before: YANTAI YENE BIOMEDICAL TECHNOLOGY Co.,Ltd. Country or region before: China Patentee before: NANJING KANGBOSI PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |